Subject: CIIX Sub CBD Biotechnology Co. Ltd., Lunches CBD Wine

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
CIIX Sub CBD Biotechnology Co. Ltd., Lunches CBD Wine
Hot Stock to WatchHot Stock to Watch

Company: ChineseInvestors.com, Inc. (OTCQB: CIIX)


Last:

Price: 0.50

Change (%): + 0.01 (2.04)

Volume: 23,876
CIIX Chart

Just in Time for Chinese New Year, ChineseInvestors.com Inc. Announces CBD Biotechnology Co. Ltd.'s Sales Kickoff of Hemp Wine In China

Hemp Wine, launched by Chineseinvestors.com, Inc’s wholly owned foreign enterprise CBD Biotechnology Co. Ltd., is a proprietary blend made from carefully selected ingredients including hemp and ginseng, designed specifically for the global Chinese wellness market

SAN GABRIEL, California, January 16, 2019 /PRNewswire/ – ChineseInvestors.com, Inc. (OTCQB: CIIX), the premier online financial information provider for Chinese investors, announced today that its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (“CBD Biotech”), officially launched its first self-branded rice wine alcohol product, Hemp Wine. CBD Biotech will begin offering Hemp Wine gift sets off-line immediately along with its other leading alcohol product, Wuliangye Nafu liquor, a Chinese baijiu, with an official on-line sales launch to follow shortly thereafter.

CBD Biotech is proud to collaborate with The Institute of Longevity of the Elderly in Bama, Guangxi for the official launch of Hemp Wine, said Summer Yun, CBD Biotech’s CEO. “This is a natural collaboration as hemp rice wine originated in Bama, one of the world’s five longevity towns in terms of the distribution rate of centenarians, often referred to as the ‘longevity capital of China.’ Moreover, this launch coincides with the upcoming Chinese New Year, a holiday surrounded by celebrations and gifting, setting the stage for the Hemp Wine gift sets to be a huge success,” Yun continued.

“Over the past year, CBD Biotech has put many drivers in place for future growth,” said Alex Hamilton, CFO of CBD Biotech. “We are excited about the progress that CBD Biotech has made in China with our hemp product offerings, beginning with our industrial hemp-infused CBD skincare line, and now including our newly launched hemp rice wine beverage. CBD Biotech will continue to develop new, innovative hemp and CBD products to serve the growing demand in China and will use targeted marketing campaigns to expand is brand awareness.”

Continue Reading


IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks